ABSTRACT

Given the continuing development of new statins and their increasing, beneficial use in clinical practice and given the importance of clinical research into the atherosclerotic plaque and its role in cardiovascular and endovascular diseases, given the immense advances in animal and human studies that have taken place over the past few years at a st

chapter |17 pages

Oxidation of LDL

chapter |26 pages

Intravascular ultrasound (IVUS)

part |2 pages

Peripheral arterial disease

chapter |7 pages

References

chapter 5|22 pages

Plaque stabilization and lipid lowering in clinical practice

J Wouter Jukema, Frank LJ Visseren and Gerard Pasterkamp Introduction: the (natural) dynamics of coronary atherosclerosis

chapter |4 pages

References

chapter |7 pages

Stroke

part |1 pages

Other possible applications of statins

chapter |4 pages

References

chapter 8|11 pages

Current position of fibrate therapy in clinical practice

Mikko Syvänne and Marja-Riitta Taskinen

chapter |5 pages

Summary

chapter 9|10 pages

Diabetic dyslipidaemia

Marc Evans and Alan Rees

part |1 pages

Postprandial lipaemia, endothelial dysfunction and oxidative stress in type 2 diabetes mellitus

chapter |12 pages

Management of diabetic dyslipidaemia

chapter 10|16 pages

Future lipid-lowering drug development

Chris J Packard Background

chapter |7 pages

References

chapter 11|5 pages

Future clinical trials of lipid-lowering drugs

John C LaRosa

part |2 pages

Aggressive cholesterol lowering

chapter |9 pages

Special populations